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Primitive neuroectodermal tumor (PNET) of the chest wall or Askin’s tumor is a rare neoplasm of chest wall. It most often aﬀects
children and adolescents and is a very rare tumor in adults. In this case report, we present an Askin’s tumor occurred in a 73-
year-old male. The patient was admitted with a history of 3-month lower back pain and cough. In computed tomography, there
was a lesion with dimensions of 70 × 40 × 65mm in the superior segment of the lower lobe of the left lung. Positron emission
tomography/computedtomographywith18F-ﬂourodeoxyglucoserevealedapleural-basedtumorintheleftlungwithamaximum
standardized uptake value of 4.36. No distant or lymph node metastases were present. The patient had gone through surgery, and
wedge resection of the superior segment of left lobe and partial resection of the ipsilateral ribs were performed. Pathology report
with immunocytochemistry was consistent with PNET and the patient received chemotherapy after that.
Copyright © 2009 Gonca Kara Gedik et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Primitive neuroectodermal tumors (PNETs) and Ewing Sar-
coma are closely related malignant, small, round-cell tumors
of soft tissues and bones [1]. Both of them strongly express
the glycoprotein p30/32(CD99) encoded by MIC2 gene [1].
Recently, PNET and Ewing sarcoma have been categorized
intoagroupknownastheEwingfamilyoftumorsbecauseof
their immunohistochemical, ultrastructural, and molecular
similarities.
P N E T sa r em a l i g n a n tt u m o r so ft h ec e n t r a ln e r v o u s
system and usually found in infants, children, and young
adults. PNETs arise from the primitive nerve cells of the
nervous system but they can also occur in outside the central
nervous system (peripheral PNETs) including bone in the
extremities, pelvis, and the chest wall.
P N E T so ft h ec h e s tw a l lw e r eo r i g i n a l l yr e p o r t e db y
Askin et al. [2] in 1979 in 20 children and adolescents with
a mean age of 14 years. Since that time, PNETs localized
in thoracopulmonary region have been deﬁned as Askin’s
tumors.
Herein, we report a 73-year-old male patient with Askin’s
tumor and describe ﬁndings on dual-modality positron
emissiontomography/computedtomography(PET/CT)car-
ried out with 18F-ﬂourodeoxyglucose (18F-FDG). Askin’s
tumor is a disease of pediatric age group and few young
adultshavebeenreported[3,4].Inolderagegroup,wefound
only one reported case of Askin’s tumor presented at age of
67 [5]. We report here one further case of Askin’s tumor
occurred in older age.
2.CaseReport
A 73-year-old male patient without any history of smoking
was admitted to hospital for lower back pain and cough
on January 2009. From his history it was learnt that he
was suﬀering from these symptoms for the last 3 months.
Computed tomography conﬁrmed the presence of a lesion2 Case Reports in Medicine
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Figure 1: Axial (a) and sagittal (b) CT images demonstrate a lesion
in the upper lobe of the left lung invading pleura and adjacent ribs
(arrows).
with dimensions of 70×40×65mm in the superior segment
of the lower lobe of left lung. Invasion to the pleura and
ipsilateral 6th, 7th, and 8th were also observed (Figures 1(a)
and 1(b)). Fine-needle aspiration puncture performed with
the guide of CT was suspicious for small cell carcinoma of
the lung. Laboratory tests were in normal limits.
The patient referred to nuclear medicine department
for PET/CT. Dual-modality PET/CT imaging was performed
after intravenous injection of 370 Mega Bequerel (10mCi)
18F-FDG with a PET/CT scanner (Biograph, Siemens) from
the top of the head to the middle of the thigh. Positron
emission tomography attenuation correction was based on
the CT data and coregistered attenuation corrected PET
image and CT image were reviewed.
PET/CT revealed a lesion in the superior segment of the
lower lobe of left lung. Maximum calculated standardized
uptake value (SUVmax) of the lesion was 4.36 (Figure 2).
No additional ﬁndings including lymph node or distant
metastases were noted in PET/CT.
Since no distant and lymph node metastases were
present and the patient was operable, he had gone through
surgery. During surgery, a lesion arising from the chest
wall, inﬁltrating the adjacent ribs, was identiﬁed. Left
thoracotomy, wedge resection of superior segment of the
lower lobe of left lung, and partial resection of 6th, 7th,
and 8th ribs were performed. Light microscopy showed
small size round cells with scanty cytoplasm assembling in
F
Figure 2: Axial-fused PET/CT image shows a pleural-based tumor
with a calculated SUVmax of 4.36 (arrow).
Figure 3: Small-sized round cells with scanty cytoplasm were seen
in light microscopic evaluation (×40).
alveolar structures (Figure 3). After immunohistochemical
analysis which showed positivity for CD 99, vimentine and
synaptophysin (Figures 4(a), 4(b),a n d4(c)), diagnosis of
PNET was made. He is well and alive after 4 cycles of
chemotherapy including adriamycine, cyclophosphamide,
and vincryistine.
3. Discussion
PNET of chest wall is a distinct clinical and pathological
entity arising from the soft tissue of the chest wall, occasion-
ally from the rib cage and rarely from the periphery of the
lung [6].
Radiologic features of central and peripheral PNETs have
been documented [6, 7]. Soft tissue density and uncommon
calciﬁcation were described on CT [6]. On magnetic reso-
nance imaging (MRI), lesions were hyperintense compared
to muscle on T1-weighted sequences and showed generally
high and heterogenous signal on T2-weighted sequences
[6]. Computed tomography was reported as valuable for
evaluating tumor extension at diagnosis and response to
chemotherapy [6]. Magnetic resonance imaging was foundCase Reports in Medicine 3
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Figure 4: Immunohistochemistry revealed positivity with (a) CD
99, (b) vimentine, and (c) synaptophysin (×400).
to be complementary to CT especially in the evaluation of
extension of very large chest wall tumors [6].
In spite of the well-known radiologic features, limited
dataexistsintherespectoftheuseofPET/CTfusionimaging
in PNETs. Belonging to the same family, PET/CT has been
shown to be useful for the detection of recurrence in Ewing
sarcoma [8]. PET/CT was also reported to be useful in
monitoring response to chemotherapy, radiotherapy, and
postoperative evaluation of tumor resection sites in child-
hood sarcomas including Ewing sarcoma by By McCarville
et al. [9].
Ewing family of tumors are high-grade malignancies
which causes to expect high standardized uptake values
(SUVs). However, reported SUVs are not high. Gy¨ orke et al.
[10] studied the impact of FDG PET for staging of Ewing
sarcomas and PNETs and reported a mean SUV of 4.54 ±
2.79. Moreover, diﬀerent SUVs were observed among pri-
mary tumors and metastases and this was attributed to
diﬀerent expression of glucose transporters in primaries and
metastases. In that study, relatively low SUVs were also seen
in lesions less than 15mm and partial volume eﬀect was
discussed as a cause for low SUVs.
In our patient, SUVmax of the lesion was calculated
as 4.36 which was low like the other Ewing family of
tumors and concordant with the ﬁndings of Gy¨ orke et al.
[10]. However, since the lowest dimension of the tumor of
this patient was 40mm, we thought that the expression of
glucose transporters may be low in Ewing family of tumors
compared to other high-grade malignancies and this may be
an explanation for the low SUVs instead of partial volume
eﬀect.
Except bronchoalveolar carcinomas, carcinoid tumors,
and some subcentimeter-sized adenocarcinomas, FDG
uptake is usually high in lung tumors. In a study by
Tournoy et al., the role of 18F-FDG PET/CT in the staging
of mediastinal lymph nodes was investigated and mean
SUVmax of 8.34 was reported among all histologic subtypes
ofnonsmallcellcarcinomas[11].Sobesidesbronchoalveolar
carcinomas and carcinoids, PNETs of the thoracic wall
should also be considered in the diﬀerential diagnosis of
tumors in the thoracopulmonary region when low SUV is
calculated in PET/CT.
The present case is unusual for the age of presentation
anddemonstratingthe18F-FDGPET/CTﬁndings.Reported
adult patients with Askin’s tumor are usually young adults.
Our patient is older than the reported patients previously.
We concluded that Askin’s tumor must be kept in mind as
one etiologic possibility in small round cell tumors of the
thoracic wall not only in children and young adults but also
in elderly. PET/CT may be helpful for characterization of
the metabolic activity of the tumor and for investigation of
distant metastases.
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